Free Trial

Sonnet BioTherapeutics (SONN) Competitors

Sonnet BioTherapeutics logo
$2.90 -0.02 (-0.68%)
(As of 11/21/2024 ET)
No competitors for Sonnet BioTherapeutics were found.

Get Sonnet BioTherapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SONN and its competitors with MarketBeat's FREE daily newsletter.

SONN vs. The Competition

MetricSonnet BioTherapeuticsPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.97M$6.51B$5.09B$8.84B
Dividend YieldN/A8.11%5.04%4.07%
P/E RatioN/A6.16101.4814.96
Price / Sales13.15366.491,207.9887.23
Price / CashN/A52.5939.7136.27
Price / Book-2.8210.176.936.35
Net Income-$18.83M$153.13M$118.81M$225.93M
7 Day Performance-3.33%-1.61%-1.39%-0.03%
1 Month Performance-49.21%-7.15%-3.29%2.00%
1 Year Performance113.24%31.67%32.29%27.82%

Related Companies and Tools


This page (NASDAQ:SONN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners